Navigation Links
Rhode Island Hospital fellow receives funding to support research in myocardial perfusion
Date:6/7/2011

(Providence, R.I.) Antonio Lassaletta, M.D., a fellow in cardiothoracic surgery research at Rhode Island Hospital, has been awarded a Research Fellowship from the Thoracic Surgery Foundation for Research and Education (TSFRE) to support his project, "Improving Myocardial Perfusion in a Diabetic Swine Model of Chronic Cardiac Ischemia." TSFRE awarded just two Research Fellowships in 2011; Lassaletta's fellowship is for two years.

TSFRE fellowships are designed to provide salary and/or direct experimental support for surgeons and surgical trainees who wish to acquire research skills. Particular emphasis is placed on evidence of supervisory interaction in the training environment. Lassaletta's research is being conducted under the guidance of Frank Sellke, M.D., chief of cardiothoracic surgery at Rhode Island Hospital and The Miriam Hospital. Sellke is nationally and internationally recognized for his clinical skills, commitment to excellence in patient care, and seminal and cutting-edge National Institutes of Health-supported cardiovascular research.

"Dr. Lassaletta has demonstrated a strong commitment to cardiothoracic care," said Sellke. "His work ethic and dedication to furthering patient care through research findings is commendable, and this fellowship is greatly deserved. The TSFRE is very selective in determining the recipients of these fellowships, and I am encouraged by their support of Dr. Lassaletta and his work."

Lassaletta's research measures the changes in blood supply to the heart in swine in order to investigate the effects of regenerative medicine. His goal is to determine if swine with Type I diabetes, suffering from reduced blood flow to the heart possibly brought on by coronary artery disease, will show improvement after the subjects receive a surgically implanted pump that encourages blood vessel growth in the heart, and that these improvements will be sustained with the addition of resveratrol. Resveratrol is a widely used FDA-unregulated supplement that has shown improved blood flow to the heart in humans.

The purpose of The Thoracic Surgery Foundation for Research and Education is to increase the knowledge base of cardiothoracic surgery and to enhance the knowledge of all thoracic surgeons so that ultimately patients may be better served. The TSFRE is committed to increasing resources by enlisting the participation of all thoracic surgeons and others who support its purpose. The Thoracic Surgery Foundation for Research and Education supports research and education initiatives to:

  • Increase knowledge and enhance treatment of patients with cardiothoracic diseases
  • Develop the skills of cardiothoracic surgeons as surgeon-scientists and health policy leaders
  • Strengthen society's understanding and trust in the profession


'/>"/>

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan
Source:Eurekalert

Related medicine news :

1. Rhode Island Settlement Reflects Homeowner Liability for Serving Alcohol to Those Under 21, Says Providence Lawyer Mark Gemma
2. Rhode Island Hospital physician receives national award for research
3. Women & Infants launches Rhode Island Network for Pelvic Floor Disorders
4. Paper by Rhode Island Hospital physician selected among best of 2010 by JACR
5. Tishman Speyer Hosts Government, Union and Civic Leaders for Topping Out of Gotham Center Tower in Long Island City
6. Long Island Pediatric Group Announces Policy Changes That Will Help More New Yorkers
7. Long Island Press Investigates Big Tobacco's Lobby to Kill Indian Cigarette Trade
8. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
9. New Aspen Dental Office Opens in Grand Island, Nebraska
10. Relevant Public Relations President Barton Horowitz of Staten Island, N.Y., Chamber CEO Linda Baran Applauded By Congressman McMahon as SBA Honorees
11. Cyberknife of Long Island Destroys Prostate Cancer Non-Invasively Using Radiosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... CareAcademy, ... that it has raised $1.675 M in seed funding to further expand its ... and Techstars Venture Capital Fund are the company’s primary investors. , ...
(Date:8/17/2017)... ... , ... Centrifugation is more than just spinning. Like a car in our ... do without. And just like a car, there are a few points to consider ... will learn about the most important safety aspects while using a centrifuge, as well ...
(Date:8/16/2017)... ... , ... The next Patient Care Academy at Kalamazoo Valley Community College begins ... the seven-week long Patient Care Academy are eligible to take the State of Michigan ... CNA in Kalamazoo is $24,428.* , As a CNA, one is equipped for employment ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , ... development, today announced Cumberland Skin Surgery and Dermatology has joined the ... offices in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) today announced ... Aug. 7, 2017. ... and will serve as president emeritus during a planned, 90-day ... multiple leadership roles since he joined Diplomat with the acquisition ... decisive, strategic leadership which continues to benefit our patients and ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
Breaking Medicine Technology: